<div class="docx-content">
<h2 class="text-xl font-semibold mt-6 mb-3"><strong>Management of Prion Exposure in the Hospital Setting</strong></h2><h3 class="text-lg font-semibold mt-6 mb-3"><strong>1. Background</strong></h3><ul><li>Prion diseases (transmissible spongiform encephalopathies – TSEs) include <strong>sporadic, familial, iatrogenic, and variant CJD (vCJD)</strong>.</li><li><strong>Iatrogenic transmission</strong> arises from contaminated surgical instruments, grafts, hormones, or blood.</li><li><strong>Prions resist conventional sterilisation</strong>: unaffected by standard autoclaving, formalin, or routine chlorine concentrations.</li><li>Therefore, specialised <strong>identification, instrument management, and decontamination protocols</strong> are required to prevent secondary transmission.</li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>2. Identification of At-Risk Patients</strong></h3><p><strong>All surgical or endoscopic patients</strong> must be asked:</p><p>“Have you ever been notified that you are at increased risk of CJD or vCJD?”</p><p><strong>High-risk categories</strong></p><ul><li><strong>Genetic/familial risk:</strong> ≥ 2 affected relatives, or known <em>PRNP</em> mutation.</li><li><strong>Iatrogenic exposures:</strong><ul><li>Recipients of human pituitary-derived hormones (pre-1985).</li><li>Recipients of cadaveric dura mater grafts (pre-1992).</li><li>Recipients of <strong>UK-sourced plasma products 1990–2001</strong>.</li><li>Recipients of blood or components from ≥ 300 donors since 1990.</li><li>Recipients of blood/organs from donors who later developed vCJD.</li></ul></li><li><strong>Clinical suspicion:</strong> progressive, unexplained neurodegenerative illness where CJD cannot be excluded.</li></ul><p>If patient cannot be categorised with certainty, <strong>consult IPC</strong> and treat as “increased risk.”</p><h3 class="text-lg font-semibold mt-6 mb-3"><strong>3. Tissue and Procedure Risk Stratification</strong></h3><table><tr><td><p><strong>Risk level</strong></p></td><td><p><strong>Examples of tissues</strong></p></td><td><p><strong>Key notes</strong></p></td></tr><tr><td><p><strong>High</strong></p></td><td><p>Brain, spinal cord, cranial ganglia, posterior eye, pituitary</p></td><td><p>All CJD types</p></td></tr><tr><td><p><strong>Medium</strong></p></td><td><p>Spinal ganglia, olfactory epithelium; in vCJD also lymphoid tissues (tonsil, spleen, thymus, appendix, Peyer’s patches)</p></td><td><p>vCJD adds lymphoid sites</p></td></tr><tr><td><p><strong>Low</strong></p></td><td><p>Blood, CSF, urine, saliva, other viscera</p></td><td><p>No special precautions</p></td></tr></table><p><strong>Procedures:</strong> any invasive or tissue-vaporising procedure (biopsy, diathermy) breaching mucosa in these sites.</p><h3 class="text-lg font-semibold mt-6 mb-3"><strong>4. Instrument and Equipment Management</strong></h3><h4 class="text-base font-semibold mt-4 mb-2"><strong>Single-Use Instruments</strong></h4><ul><li><strong>Preferred</strong> for any procedure involving high/medium-risk tissue.</li><li>Must be <strong>incinerated after use</strong> (never reprocessed).</li></ul><h4 class="text-base font-semibold mt-4 mb-2"><strong>Reusable Instruments</strong></h4><ul><li><strong>Tracking/traceability systems</strong> mandatory (link sets ↔ patient).</li><li><strong>Immediate handling:</strong><ul><li>Keep moist (within 3 h) to avoid prion fixation; prevent pooling water.</li><li>Transport in sealed, labelled containers (“Used medical device – CJD risk”).</li></ul></li><li><strong>Quarantine procedure:</strong><ul><li>Remove gross soil at point of use under running water (avoid splashes).</li><li>Reprocess through sterile services, then <strong>seal in rigid, labelled container</strong>.</li><li>Store securely pending diagnostic confirmation.</li><li>If CJD excluded → reprocess and return.</li><li>If confirmed → <strong>incinerate</strong> or retain for <strong>dedicated reuse on the same patient only</strong> (after specialist advice).</li></ul></li><li><strong>Complex instruments</strong> (e.g. drills, microscopes): use disposable sheaths; destroy bits/tips that contact tissue.</li><li><strong>Loan equipment:</strong> must enter tracking system before use.</li></ul><h4 class="text-base font-semibold mt-4 mb-2"><strong>Waste Disposal</strong></h4><ul><li>All waste from high/medium-risk tissues (filters, tissues, fluids) → <strong>incineration</strong>.</li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>5. Decontamination Procedures</strong></h3><p><strong>Key principles:</strong></p><ul><li><strong>Manual cleaning</strong> before sterilisation is essential.</li><li><strong>Never use fixative disinfectants</strong> (alcohol, aldehydes, OPA, glutaraldehyde) – these bind prions to surfaces.</li></ul><p><strong>Validated inactivation options:</strong></p><table><tr><td><p><strong>Method</strong></p></td><td><p><strong>Parameters</strong></p></td><td><p><strong>Notes</strong></p></td></tr><tr><td><p>Autoclave (porous load)</p></td><td><p>≥ 134 °C for 18–20 min</p></td><td><p>Standard UK/WHO method</p></td></tr><tr><td><p>Autoclave (gravity displacement)</p></td><td><p>132 °C for 1 h</p></td><td><p>Acceptable alternative</p></td></tr><tr><td><p>Chemical</p></td><td><p>1 M NaOH or 20 000 ppm available chlorine for 1 h</p></td><td><p>For soaking, surface cleaning</p></td></tr><tr><td><p>Combination</p></td><td><p>NaOH soak → autoclave 121–134 °C</p></td><td><p>Most effective</p></td></tr><tr><td><p>Surfaces</p></td><td><p>Clean with NaOH/hypochlorite → rinse thoroughly</p></td><td><p>Protects metalwork</p></td></tr></table><h3 class="text-lg font-semibold mt-6 mb-3"><strong>6. Endoscopy and Flexible Instrument Guidance</strong></h3><ul><li><strong>Routine GI endoscopy</strong> → low risk; standard HTM 01-06 reprocessing.</li><li><strong>Higher-risk procedures:</strong> tonsillar or rectal biopsies, invasive lymphoid sampling in “increased-risk” or “suspected vCJD” patients.<ul><li>Use <strong>dedicated/dedicated-pool endoscopes</strong>.</li><li>If exposure occurs, <strong>quarantine or destroy</strong> endoscope.</li><li>Once a patient has had a high-risk procedure, they remain assigned to that high-risk pool for future use.</li></ul></li><li><strong>Endoscope washer–disinfectors (EWDs):</strong><ul><li>Process suspected/confirmed CJD devices <strong>separately</strong> with single-use disinfectant.</li><li>Run additional rinse cycle before next routine use.</li></ul></li><li><strong>Neuroendoscopy:</strong> maintain separate instrument pools for those born ≥ 1 Jan 1997 who have not had previous high-risk procedures.</li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>7. Special Protocols</strong></h3><p><strong>Brain Biopsy / Neurosurgery</strong></p><ul><li>Use single-use instruments where possible.</li><li>Otherwise, wash immediately and quarantine the set.</li><li>Send unfixed tissue to neuropathology.</li><li>If CJD confirmed → destroy set; if excluded → release.</li></ul><p><strong>Research Use</strong></p><ul><li>Quarantined sets may be transferred for authorised research under DHSC arrangements.</li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>8. Laboratory Safety</strong></h3><ul><li><strong>Containment level:</strong><ul><li>CL 3 for brain, spinal cord, posterior eye, pituitary, cranial ganglia, and lymphoid tissues (vCJD).</li><li>CL 2 for blood, CSF, urine, saliva, and other low-risk material.</li></ul></li><li><strong>PPE:</strong> gloves, face/eye protection; cut-resistant gloves for sharps.</li><li><strong>Spill management:</strong> absorb → treat with NaOH/hypochlorite → incinerate waste.</li><li><strong>Record-keeping:</strong> exposure records ≥ 30–40 years.</li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>9. Staff Safety, Training, and Facility Design</strong></h3><ul><li>Dedicated dirty → clean workflow areas; ideally physically separate.</li><li>Staff trained in prion-safe procedures; occupational-health files retained ≥ 30 years.</li><li>Never process CJD-exposed items in general EWD cycles.</li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>10. Governance and Documentation</strong></h3><ul><li>Trusts must have protocols for:<ul><li>Pre-operative screening and patient flagging.</li><li>Instrument/endoscope tracking and quarantine.</li><li>Notification of Sterile Services Dept (SSD) for quarantine actions.</li><li>Staff training, counselling, and psychological support post-exposure.</li></ul></li><li>Comprehensive traceability logs: patient ID, instrument ID, decontamination cycle, operator, EWD details.</li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>11. Key Exam Take-Home Points</strong></h3><ul><li>Always assess <strong>patient risk + tissue risk</strong>.</li><li><strong>Single-use, incinerate</strong> if possible.</li><li>If reuse unavoidable: <strong>keep moist, label, quarantine, and track.</strong></li><li><strong>Validated inactivation:</strong> 134 °C ≥ 18 min, or NaOH + autoclave; never use aldehydes.</li><li><strong>Endoscopes:</strong> dedicated pool or quarantine; destroy if exposed to lymphoid tissue in “at-risk” patient.</li><li><strong>CNS/lymphoid lab work = CL 3;</strong> blood/CSF = CL 2.</li><li><strong>Documentation, governance, and staff training</strong> are as vital as decontamination itself.</li></ul><p>✅ <strong>Summary</strong></p><p>For any patient at increased or uncertain risk of CJD/vCJD, minimise exposure of high- and medium-infectivity tissues, use single-use instruments wherever possible, and incinerate after use.<br /> Reusable instruments must be quarantined, tracked, and either destroyed or subjected to validated prion-inactivation (autoclave ≥ 134 °C or NaOH + heat).<br /> Endoscopes and complex devices require dedicated pools and strict separation.<br /> Effective governance, traceability, and trained staff underpin safe practice and are core to FRCPath Part 2 understanding.</p>
</div>